893

Pfizer licenses cancer immune therapy from VLST, which is prepared to start mid-stage testing
Yahoo/AP
Fri, 08/31/12 - 12:34 pm
Pfizer
immune therapy
VLST
CP-870
893
Pfizer Drug Slows Pancreatic Tumors in New Attack on Cancer
Bloomberg
Thu, 03/24/11 - 03:15 pm
Pfizer
pancreatic cancer
CP- 870
893
Eli Lilly
Gemzar